Use of Octa V.I. in patients with severe hemophilia
Tjønnfiord, G.; Stavem, P.; Brosstad, F.; Stormorken, H.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 109(19-21): 2053-2054
1989
ISSN/ISBN: 0029-2001 PMID: 2501908 Document Number: 332715
Document emailed within 1 workday
Related Documents
Lutze, G.; Schlote, A.; Beyer, H.; Kropf, S. 1985: Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 40(16): 479-483Ambriz-Fernández, R.; Reyna-Fregoso, M.P.; Pizzuto-Chávez, J.; Rodríguez-Moyado, H.; Farfán-Canto, J.M.; Trueba-Christy, E.; Collazo-Jaloma, J. 1985: Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. a study of the cooperative group of hemophilia Archivos de Investigacion Medica 16(3): 225-235
Klimenko, L.A.; Tkachenko, N.S.; Klimenko, L.F. 1994: Healing of severe burns in a patient with hemophilia Klinicheskaia Khirurgiia 4: 63-64
Dyszy Laube, B.; Kanabus, I.; Markocki, Z.; Bereza, M. 1973: Successful nephrectomy in a 3 and one-half-year old boy with severe hemophilia A Pediatria Polska 45(10): 1243-1247
Chuansumrit, A.; Sasanakul, W.; Goodeve, A.; Treratvirapong, T.; Parinayok, R.; Pintadit, P.; Hathirat, P. 1999: Inversion of intron 22 of the factor VIIi gene in a girl with severe hemophilia a and Turner's syndrome Thrombosis and Haemostasis 82(4): 1379
Bovenzi, F.; De Luca, L.; Signore, N.; Fusco, F.; de Luca, I. 2003: Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4(10): 728-730
Seita, I.; Shinozawa, K.; Otaki, M.; Fujita, S.; Suzuki, T.; Amano, K.; Inaba, H.; Fukutake, K. 2009: Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B Rinsho Byori. Japanese Journal of Clinical Pathology 57(5): 417-424
Vianello, F.; Zanon, E.; Zerbinati, P.; Innella, B.; Girolami, A. 2000: Disappearance of FVIIi inhibitors in a severe hemophilia a neonate after steroid treatment correlated with a cytokine shift toward a T-helper 2 pattern Haematologica 85(10): 1114-1115
Murai, M.; Kakehi, H.; Komatsu, H.; Ishimitsu, S.; Okada, S. 1991: Potassium Sucrose Octa Sulfate Reference Standard (Control 901) of National Institute of Hygienic Sciences Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences 1991(109): 171-172
Sokolov, A.N.; Savchenko, V.G.; Trakhtenberg, A.K.; Andreev, I.N.; Tochenov, A.V.; Isaev, V.G.; Skidan, N.I.; Chemis, A.G.; Vishnevskaia, E.S.; Togonidze, D.K. 2001: Effective combined treatment of thymus carcinoma with complete eradication of tumor after neoadjuvant therapy in a patient with severe form of hemophilia a Terapevticheskii Arkhiv 73(7): 70-72
Poort, S.R.; Briët, E.; Bertina, R.M.; Reitsma, P.H. 1990: Two mutations of the factor IX gene including a donor splice consensus deletion and a point mutation in a Dutch patient with severe hemophilia B Thrombosis and Haemostasis 64(3): 379-384
Lillicrap, D.P.; Bridge, P.J.; Giles, A.R. 1990: Organization of a hemophilia genetic screening program. Ontario Hemophilia Study Group Progress in Clinical and Biological Research 324: 19-28
Nichols, S.; Mahoney, E.M.; Sirois, P.A.; Bordeaux, J.D.; Stehbens, J.A.; Loveland, K.A.; Amodei, N. 2000: HIV-associated changes in adaptive, emotional, and behavioral functioning in children and adolescents with hemophilia: results from the Hemophilia Growth and Development Study Journal of Pediatric Psychology 25(8): 545-556
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Antonarakis, S.E.; Kazazian, H.H. 1990: The molecular basis of hemophilia A (factor VIII deficiency) in man; progress report from the Johns Hopkins University Hemophilia Project Progress in Clinical and Biological Research 324: 1-11
Jones, P. 1979: Organization of hemophilia therapy. the role of the hemophilia center Sangre 24(5-C): 998-1004
Girolami, A.; Dal Bo Zanon, R.; Procidano, M. 1981: Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1 Folia Haematologica 108(6): 863-871
Magallón Martínez, M.; Ortega, F.; Pinilla, J. 1992: AIDS and hemophilia: experience in the La Paz Hemophilia Center Haemostasis 22(5): 281-292
Walker, I.; Poon, M.C. 1992: Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors Group Lancet 339(8784): 61-62
Ingerslev, J.; Christiansen, S.E.; Kristensen, T.; Wallevik, K.; Bernvil, S.S. 1985: Treatment of hemophilia a and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP). Hemophilia and DDAVP Ugeskrift for Laeger 147(45): 3592-3594